Clinical Trials Directory

Trials / Completed

CompletedNCT00559676

Study of Biomarkers in Patients Undergoing Chemotherapy for Metastatic Colorectal Cancer

Phase 4 Study to Characterize and Evaluate Markers of Chemoresistance in Patients With Metastatic Colorectal Cancer

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Centre Hospital Regional Universitaire de Limoges · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

RATIONALE: Studying samples of blood and tumor tissue in the laboratory from patients with cancer receiving chemotherapy may help doctors understand the effect of chemotherapy on biomarkers. It may also help doctors predict how patients will respond to treatment. PURPOSE: This phase IV trial is studying biomarkers in patients undergoing chemotherapy for metastatic colorectal cancer.

Detailed description

OBJECTIVES: Primary * Research the oncogenetic parameters and pharmacogenetic and pharmacokinetic predictors of therapeutic response and toxic effects. Secondary * Study the correlations between the pharmacogenetic and pharmacokinetic parameters. * Study the predictive value of these parameters on disease-free and overall survival. OUTLINE: This is a multicenter study. Patients receive 1 of 4 chemotherapy regimens: * Regimen 1: Fluorouracil and leucovorin calcium * Regimen 2: Capecitabine and leucovorin calcium * Regimen 3: Irinotecan hydrochloride * Regimen 4: Oxaliplatin Tumor and blood samples are collected before the start of chemotherapy and are examined by pharmacogenetic analysis. Clinical and biological parameters are also studied. Blood samples are also collected during the first course of chemotherapy for pharmacokinetic studies. After completion of study therapy, patients are followed periodically for 3 years.

Conditions

Interventions

TypeNameDescription
DRUGcapecitabine
DRUGfluorouracil
DRUGirinotecan hydrochloride
DRUGleucovorin calcium
DRUGoxaliplatin
OTHERlaboratory biomarker analysis
OTHERpharmacological study

Timeline

Start date
2005-03-01
Primary completion
2011-05-01
First posted
2007-11-16
Last updated
2011-05-16

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00559676. Inclusion in this directory is not an endorsement.